|
|||||
|
|
National seroepidemiological study of COVID-19 after the initial rollout of vaccines: Before and at the peak of the Omicron-dominant period in Japan |
|
| Authors: | Takeshi Arashiro Satoru Arai Ryo Kinoshita Kanako Otani Sho Miyamoto Daisuke Yoneoka Taro Kamigaki Hiromizu Takahashi Hiromi Hibino Mai Okuyama Ai Hayashi Fuka Kikuchi Saeko Morino Sayaka Takanashi Takaji Wakita Keiko Tanaka-Taya Tadaki Suzuki Motoi Suzuki |
| Affiliation: | 1. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan;2. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Conceptualization (equal), Investigation (equal), Project administration (equal), Writing - review & editing (equal);3. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Data curation (equal), Formal analysis (equal), Validation (equal), Visualization (equal), Writing - review & editing (supporting);4. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Data curation (equal), Formal analysis (equal), Validation (equal), Writing - review & editing (supporting);5. Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Data curation (equal), Formal analysis (equal), Validation (equal), Visualization (equal), Writing - review & editing (supporting);6. Infectious Disease Emergency Specialist (IDES) Training Program, Ministry of Health, Labour and Welfare, Tokyo, Japan Contribution: Conceptualization (equal), Funding acquisition (equal), Investigation (supporting), Writing - review & editing (supporting);7. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Investigation (supporting);8. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Investigation (supporting), Writing - review & editing (supporting);9. National Institute of Infectious Diseases, Tokyo, Japan Contribution: Funding acquisition (supporting), Investigation (supporting), Resources (lead), Writing - review & editing (supporting);10. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Conceptualization (equal), Investigation (equal), Writing - review & editing (equal);11. Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan;12. Center for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan Contribution: Conceptualization (equal), Funding acquisition (equal), Investigation (equal), Supervision (equal), Writing - review & editing (equal) |
| Abstract: | |
| Keywords: | coronavirus disease 2019 (COVID-19) humoral immunity Japan seroepidemiologic studies severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines |